Last updated on February 2018

A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Bone marrow disorder | Mucositis | Salivary Gland Disease | Nasopharyngeal Cancer
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Nasopharyngeal cancer patients diagnosed by pathology or cytology
  • UICC/AJCC 2010 Stage T1-4 N0-3 M0
  • Male or female patients with age between 18 and 75 years old
  • Karnofsky Performance Scores 60
  • Expected survival 3 months
  • Without dysfunction of heart, lung, liver, kidney and hematopoiesis
  • No previous allergic reaction to the drug

Exclusion Criteria:

  • History of alcohol or drug abuse within 3 months
  • Pregnant or lactating women
  • Currently under treatment with other similar drugs
  • Anti-hypertension drugs applied in less than 24 hours
  • Severe hypocalcemia
  • Dysfunction of heart, lung, liver, kidney or hematopoiesis
  • Severe neurological, mental or endocrine diseases
  • Previous allergic reaction to the drug
  • Patients participated in clinical trials of other drugs within last 3 months
  • Other unsuitable reason

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.